The test result is no longer the end of the story – molecular diagnostics is rewriting what comes next. Diagnostics is no longer content to sit...
Molecular diagnostics redefines healthcare–driving accessibility, equity, personalized care, and anchoring a smarter, inclusive, humane future. For most of medical history, diagnosis has been guided by the...
From infectious disease control to cancer genomics, MDx is driving a shift toward predictive and preventive medicine. MDx is revolutionizing healthcare, driving a paradigm shift from...
Molecular diagnostics is revolutionizing early disease detection, enabling faster, more accurate diagnoses and personalized treatment plans. And a promise to transform healthcare with cutting-edge technologies. Molecular...
MDx is emerging as a game-changer in the ever-evolving healthcare landscape. This scientific discipline provides valuable insights into the molecular underpinnings of diseases, and empowers healthcare...
Leveraging cutting-edge technologies and nurturing inventive ideas is the only way forward in this era marked by transformative changes. With applications across infectious diseases, oncology, hematopathology,...
Over the next seven years, the molecular diagnostics market is poised for a magnificent spike in CAGR in terms of revenue. Molecular diagnostics has emerged as...
Molecular diagnostics has become an important pillar of healthcare in the current times. With the advancements in its techniques, molecular diagnostic is benefitting clinical medical settings....
The future of medical diagnostics lies in the genomics and proteomics, thereby reassuring the significance and demand for nucleic acid amplification tests in the clinical sector....
The molecular testing result available much faster than result from culture opens a wide range of opportunities for the segment, such as testing of patients with...
Ongoing advances will continue to shape MDx landscape, not only from a technical perspective but also with interconnected logistical, financial, and regulatory factors that are critical...
It is expected to maintain its dominance in upcoming years owing to its wide adoption in research and clinical settings. Standardized results, improved efficiency, and cost-effectiveness...
As the need for COVID-19 testing collapses to a fraction of its current demand, molecular diagnostics companies will be holding and maintaining facilities that can create...
The Indian MDx market saw an additional ₹7000 crore sales on account of RT-PCR testing. As the world rushes to become vaccinated against the COVID-19, the...
The high demand for molecular diagnostics could seed structural shifts that will have long-term implications for diagnostic-test manufacturers. With high technological and regulatory barriers to entry,...
Copyright © 2026 Medical Buyer maintained by Algocept